This technology filters impurities through sample pre-processing and uses fully automated slide preparation and staining technology to achieve cell dispersion, fixation, and staining. Combined with multi-modal detection and analysis, it significantly improves the early diagnosis rate of cervical precancerous lesions. Key equipment includes automatic cervical cytology exfoliation analyzers, automatic liquid-based thinprep cytology staining machines, and blockchain cloud diagnostic big data platforms. Early diagnosis can effectively block cervical cancer onset, achieving the strategic goal of eliminating cervical cancer.

Technology provider:Guangxi Laibosai Medical Testing Co., Ltd.